CWP
NPTN

Concord Wealth Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

Concord Wealth Partners’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-157
Closed -$1K – 1365
2021
Q3 		$1K Sell
157
-200
-56% -$1.82K ﹤0.01% 889
2021
Q2 		$4K Buy
+357
New +$3.77K ﹤0.01% 794

Other funds holding NPTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Concord Wealth Partners's NPTN Position: Q4 2021 in Review

Concord Wealth Partners sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 157 shares — an estimated $1K sold.

Concord Wealth Partners first reported a position in NPTN in Q2 2021 and held it in 2 quarters. The position peaked at $4K in Q2 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • Concord Wealth Partners reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • Concord Wealth Partners sold 157 NEOPHOTONICS CORP shares in Q4 2021, an estimated $1K.
  • Concord Wealth Partners first reported a position in NEOPHOTONICS CORP in Q2 2021 and held it in 2 quarters.
  • Concord Wealth Partners's NEOPHOTONICS CORP position peaked at $4K in Q2 2021.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Concord Wealth Partners's 13F filing for Q4 2021, filed 21 Jan 2022.